PET/MRI in Brain Tumors
The DOI matches its Crossref record; 199 of the 200 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PRRT leverages radiolabelled somatostatin analogues like 177Lu-DOTATATE, utilizing their molecular specificity to target tumor cells overexpressing somatostatin receptors [101].”
From Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation (2024) · cites this paper as [101]
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1545-1 · Cited by 15,657
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
Wen, P. Y., Macdonald, D. R., Reardon, D. A., Cloughesy, T. F., Sorensen, A. G., Galanis, E., DeGroot, J., Wick, W., Gilbert, M. R., Lassman, A. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3541 · Cited by 3,836
Imaging proliferation in vivo with [F-18]FLT and positron emission tomography
Shields, A. F., Grierson, J. R., Dohmen, B. M., Machulla, H.-J., Stayanoff, J. C., Lawhorn-Crews, J. M., Obradovich, J. E., Muzik, O., & Mangner, T. J. (1998) · Nature Medicine · doi:10.1038/3337 · Cited by 1,204
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
Brandsma, D., Stalpers, L., Taal, W., Sminia, P., & van den Bent, M. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70125-6 · Cited by 1,121
Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response
Dewhirst, M. W., Cao, Y., & Moeller, B. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2397 · Cited by 1,022
Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner
Delso, G., Fürst, S., Jakoby, B., Ladebeck, R., Ganter, C., Nekolla, S. G., Schwaiger, M., & Ziegler, S. I. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.092726 · Cited by 874
The Role of Hypoxia-Induced Factors in Tumor Progression
Vaupel, P. (2004) · The Oncologist · doi:10.1634/theoncologist.9-90005-10 · Cited by 827
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
Weller, M., van den Bent, M., Hopkins, K., Tonn, J. C., Stupp, R., Falini, A., Cohen-Jonathan-Moyal, E., Frappaz, D., Henriksson, R., Balana, C., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70011-7 · Cited by 750
Research works printed but not linked: 4
- Bruzzone MG, D'Incerti L, Farina LL, Cuccarini V, Finocchiaro G. CT and MRI of brain tumors. The quarterly journal of nuclear medicine and molecular imaging: official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of…. 2012;56(2):112–37.
- Galldiks N, Stoffels G, et al. Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis. J Nucl Med. 2012;53(9):1367–74. · DOI · Paper page
- Gulyas B, Halldin C. New PET radiopharmaceuticals beyond FDG for brain tumor imaging. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of…. 2012;56(2):173–90.
- Leung K. [11C]acetate. Molecular imaging and contrast agent database (MICAD). Bethesda: National Center for Biotechnology Information (US); 2004.
Cited by
Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation
Dhoundiyal, S., Srivastava, S., Kumar, S., Singh, G., Ashique, S., Pal, R., Mishra, N., & Taghizadeh-Hesary, F. (2024) · European Journal of Medical Research · doi:10.1186/s40001-023-01627-0 · Cited by 144
“PRRT leverages radiolabelled somatostatin analogues like 177 Lu-DOTATATE, utilizing their molecular specificity to target tumor cells overexpressing somatostatin receptors [101].”
BackgroundComparison of PET/CT and PET/MRI in central nervous system tumors, a narrative review
Riahi, F., Kiani, P., Golabbakhsh, A., Khanezarrin, M., Abbaspour, M., Tabatabaei, S. A. D., Fesharaki, S., Tooyserkani, S. H., Bakhshi, R., Azizollahi, S., et al. (2024) · International Journal of Physiology Pathophysiology and Pharmacology · doi:10.62347/umds1961 · Cited by 13
Sağıroğlu, Ş., Terzi, R., Çeltikçi, E., Börcek, A. Ö., Atay, Y., Arslan, B., Şahin, M. Ç., Nernekli, K., Demirezen, M. U., Özdemir, O. B., et al. (2025) · PeerJ Computer Science · doi:10.7717/peerj-cs.2920 · Cited by 11
Metadata
- Authors
- Sonni, I., Garibotto, V., Iagaru, A., Das, D., & Massoud, T.
- Affiliations
- Stanford Medicine (US)
- University Hospital of Geneva (CH)
- Corresponding author
- Sonni, Ida
- Venue
- PET/MRI in Oncology
- Publisher
- Springer International Publishing
- Published
- 2018
- Pages
- 185-222
- OpenAlex
- W2788220988
- Cited by
- 3
- References
- 200
- Citations by year
- 2025: 1 · 2024: 2
- FWCI
- 0.00
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Springer eBooks (publishedVersion)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Keywords
- PET/MRI, brain tumors, hybrid imaging, molecular imaging, PET radiopharmaceuticals, tumor grading, tumor extent delineation, treatment response assessment, MRI techniques, neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PET/MRI in Brain Tumors. https://app.cochat.ai/papers/10.1007/978-3-319-68517-5_11
- The paper
- Sonni, I., Garibotto, V., Iagaru, A., Das, D., & Massoud, T. (2018). PET/MRI in Brain Tumors. PET/MRI in Oncology. https://doi.org/10.1007/978-3-319-68517-5_11
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.